The safety of kava: a regulatory perspective.
Richardson
W N
WN
Medicines and Healthcare products Regulatory Agency, Vigilance and Risk Management of Medicines, Market Towers, London, UK. william.richardson@mhra.gsi.gov.uk
Henderson
L
L
D003257:Consumer Product Safety / Q000331:legislation & jurisprudence*; D006801:Humans; D020901:Kava / Q000009:adverse effects*; D006113:United Kingdom